Hammel P - Search Results

1

[Therapeutic management of poorly differentiated neuroendocrine lung tumors and neuroendocrine carcinomas of the digestive system].

Pellat A, Wislez M, Svrcek M, Hammel P, Afchain P, André T. Pellat A, et al. Among authors: hammel p. Bull Cancer. 2016 Oct;103(10):880-895. doi: 10.1016/j.bulcan.2016.06.006. Epub 2016 Aug 6. Bull Cancer. 2016. PMID: 27507031 French.

2

Phase II trial of bimonthly leucovorin, 5-fluorouracil and gemcitabine for advanced pancreatic adenocarcinoma (FOLFUGEM).

Louvet C, André T, Hammel P, Selle F, Landi B, Cattan S, Fonck M, Flesch M, Colin P, Balosso J, Ruszniewski P, de Gramont A. Louvet C, et al. Among authors: hammel p. Ann Oncol. 2001 May;12(5):675-9. doi: 10.1023/a:1011139808426. Ann Oncol. 2001. PMID: 11432627 Free article. Clinical Trial.

3

Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma: final results of a GERCOR multicenter phase II study.

Louvet C, André T, Lledo G, Hammel P, Bleiberg H, Bouleuc C, Gamelin E, Flesch M, Cvitkovic E, de Gramont A. Louvet C, et al. Among authors: hammel p. J Clin Oncol. 2002 Mar 15;20(6):1512-8. doi: 10.1200/JCO.2002.20.6.1512. J Clin Oncol. 2002. PMID: 11896099 Clinical Trial.

4

Phase II study of leucovorin, 5-fluorouracil and gemcitabine for locally advanced and metastatic pancreatic cancer (FOLFUGEM 2).

André T, Noirclerc M, Hammel P, Meckenstock R, Landi B, Cattan S, Selle F, Codoul JF, Guerrier-Parmentier B, Mokhtar R, Louvet C; GERCOR. André T, et al. Among authors: hammel p. Gastroenterol Clin Biol. 2004 Aug-Sep;28(8-9):645-50. doi: 10.1016/s0399-8320(04)95042-7. Gastroenterol Clin Biol. 2004. PMID: 15646530 Free article. Review.

5

Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial.

Louvet C, Labianca R, Hammel P, Lledo G, Zampino MG, André T, Zaniboni A, Ducreux M, Aitini E, Taïeb J, Faroux R, Lepere C, de Gramont A; GERCOR; GISCAD. Louvet C, et al. Among authors: hammel p. J Clin Oncol. 2005 May 20;23(15):3509-16. doi: 10.1200/JCO.2005.06.023. J Clin Oncol. 2005. PMID: 15908661 Clinical Trial.

6

[Pancreatic cancer: what is new in 2005?].

Hammel P. Hammel P. Bull Cancer. 2006 Jan;93(1):67-72. Bull Cancer. 2006. PMID: 16455508 Free article. Review. French.

7

Cancer of the pancreas.

Andre T, Hammel P, Lacaine F, Palazzo L, Becouarn Y, Mornex F. Andre T, et al. Among authors: hammel p. Gastroenterol Clin Biol. 2006 Sep;30 Spec No 2:2S75-2S80. Gastroenterol Clin Biol. 2006. PMID: 17151566 Free article. Review. No abstract available.

8

Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies.

Huguet F, André T, Hammel P, Artru P, Balosso J, Selle F, Deniaud-Alexandre E, Ruszniewski P, Touboul E, Labianca R, de Gramont A, Louvet C. Huguet F, et al. Among authors: hammel p. J Clin Oncol. 2007 Jan 20;25(3):326-31. doi: 10.1200/JCO.2006.07.5663. J Clin Oncol. 2007. PMID: 17235048

9

[Adjuvant and neoadjuvant treatment for pancreatic adenocarcinoma in 2006].

Deberne M, Huguet F, Le Scodan R, Hammel P, Andre T. Deberne M, et al. Among authors: hammel p. Bull Cancer. 2007 Jan;94(1):72-80. Bull Cancer. 2007. PMID: 17237007 Review. French.

10

Sunitinib paves the way for targeted therapies in neuroendocrine tumors.

Raymond E, Faivre S, Hammel P, Ruszniewski P. Raymond E, et al. Among authors: hammel p. Target Oncol. 2009 Dec;4(4):253-4. doi: 10.1007/s11523-009-0130-0. Epub 2009 Nov 13. Target Oncol. 2009. PMID: 19911111

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

429 results

Search Page

Filters